Abstract C008: Tolerability and Antitumor Activity of Paclitaxel is Improved by the Addition of Nilotinib in Patients with Refractory Solid Tumors
MOLECULAR CANCER THERAPEUTICS(2019)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
MOLECULAR CANCER THERAPEUTICS(2019)